One out of 20 prescriptions written in the U.S. is for a GLP-1 drug. US doctors write billions of prescriptions each year. During 2024, though, one type of drug stood out—“wonder drugs” known as GLP-1 ...

Obesity continues to plague New Yorkers, affecting almost two out of every three adults in our state. That’s why I’m pushing ...

As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented ...

A stark warning has been issued to Brits attempting to get their hands on weight loss drugs to counteract the extra pounds piled on over the Christmas period.

Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...

Growth stocks are equity shares likely to outperform their peers and the broader market. Here's a list of stocks that contain ...

"An MDL that encompassed any potential injury relating to use of these exceedingly popular weight loss drugs might quickly ...

With U.S. headquarters in Plainsboro, Novo Nordisk told NJBIZ, "NAION is a very rare eye disease, and it is not an adverse ...

Viking Therapeutics shows promise with weight loss drug VK2735 and potential in NASH treatment, making it a potential ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Eli Lilly & Co.’s diabetes and weight-loss drugs Mounjaro and Zepbound are no longer in short supply in the US, which means ...